ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,591, issued on May 19, was assigned to JANSSEN VACCINES & PREVENTION B.V. (Leiden, Netherlands).
"Recombinant influenza antigens" was invented by Boerries Brandenburg (Leiden, Netherlands), Tina Ritschel (Leiden, Netherlands), Ferdinand Jacobus Milder (Leiden, Netherlands), Mandy Antonia Catharina Jongeneelen (Leiden, Netherlands), Indigo King (Leiden, Netherlands), Yifan Song (Leiden, Netherlands) and Johannes Petrus Maria Langedijk (Leiden, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides recombinant influenza A hemagglutinin (HA) polypeptides, comprising an HA1 and a HA2 domain of an influenza A virus HA, and compr...